With over 225 years of combined clinical and commercial experience, Diagnostic Ventures has assembled industry experts to bring our first commercial products to market, both in specific disease diagnostics as well as new platform technologies.
Brian has extensive experience in healthcare over his 30-year career. He has held leadership positions in both sales and business development roles. He also has experience as a Founder and Chairman, specifically in healthcare software-as-a-service. Brian is also a successful angel investor and has been listed as co-inventor on 2 patent applications.
Devin brings over 18 years of commercial leadership experience across operations, business development, and sales. He previously served as Vice President of Sales for a nationwide services company valued at over $250 million, where he led revenue growth and go-to-market initiatives at scale. Devin has also served as Co-Founder and Chief Operating Officer of a healthcare SaaS company, along with holding multiple senior leadership roles across both growth-stage and established organizations.
Craig is a biotech investor and life sciences executive with 25 years of experience spanning biotechnology, molecular biology, and global health. He has built a career as a CEO, co-founder, and entrepreneur, most recently co-founding Seek Labs in Salt Lake City. Craig is recognized for his strategic leadership, business development expertise, and global contacts.
Christina is a biotechnology executive with more than 25 years of experience driving commercialization and market growth across the pharmaceutical and biotech sectors. As CEO of Rapid Commercialization Partners (RCP), she works with clinical-stage companies to accelerate launch readiness and optimize market access.Christina previously held senior roles at Alexion, a division of AstraZeneca, Agile Therapeutics, and PTC Therapeutics. She holds a Master of Public Health from New York Medical College and a Bachelor of Science in Biological Science from The University of Vermont.
Ms. Gentry currently serves as Chief Clinical Officer at RenovoRx. Previously, she held senior clinical leadership roles at Evotec and spent more than a decade at Otsuka Pharmaceutical as a Director for global clinical trials and science and business strategies. Earlier in her career, she worked in clinical management roles at leading contract research organizations, including IQVIA, PPD, Omnicare CR, and IBRD-Rostrum Global. Ms. Gentry holds an M.A. from the University of Mary Hardin-Baylor and an M.S. and B.A. from the University of Central Missouri.
Mark and Norma November are mission-driven entrepreneurs and investors dedicated to solving some of the world’s most pressing challenges. Motivated by the loss of their parents to sepsis, they have invested in technologies like ours, aimed at improving patient outcomes and saving lives. They founded Venture Starters, which has grown into a dynamic, free virtual ecosystem for startups and has hosted more than 4,500 founder pitches focused on solutions to global problems. Their work centers on building, growing, and supporting companies that create meaningful, positive impact.
Ghazi brings over 25 years of experience in the medical device industry, with deep expertise across regulatory affairs, quality systems, clinical development, and product development. He has led global product registration efforts across multiple markets and brings extensive experience navigating complex regulatory environments. Ghazi has held executive roles at IdentifySensors, Lucira Health, Thermo Fisher Scientific, Becton Dickinson, and Orchid Orthopedic Solutions.
Dr. Pitt is currently a Professor in Chemical Engineering at Brigham Young University. He has extensive experience with approximately 235 publications to date.
Dr. Hill is an Assistant Professor of Genetics at Brigham Young University. He has 13 publications to date and he is a Fulbright Scholar.